Current Use of Oral Anticoagulants and Prognostic Analysis in Patients with Atrial Fibrillation Undergoing Coronary Stenting

BACKGROUND: It is currently believed that triple oral antithrombotic therapy in patients with atrial fibrillation (AF) after percutaneous coronary intervention (PCI) should be recommended if there are no contraindications. However, selecting triple therapy for AF patients undergoing PCI is still cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Heng-Bo, Liu, Jun, Dong, Zhi-Chao, Wang, Dong-Xia, Zhang, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463470/
https://www.ncbi.nlm.nih.gov/pubmed/28584203
http://dx.doi.org/10.4103/0366-6999.207460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463470/
https://www.ncbi.nlm.nih.gov/pubmed/28584203
http://dx.doi.org/10.4103/0366-6999.207460

Ejemplares similares